Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Really to much for me

<< Previous

Bullboard Posts

Next >>

Comment by Marcel49on Dec 07, 2022 1:35pm

177 Views

Post# 35156849

RE:RE:RE:Really to much for me

If 50% of the shares were sold instead of less than 2% we would have to panic but whit this small volume we can expect a positive correction soon. Sorry but I don't agree with those who think Paul and companie doesn't do a good job. This guy didn't left a good position with Pfuser to come and scrap his reputation. We just live a panic time now. Look forward.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season